Association of Myositis Autoantibodies, Clinical Features, and Environmental Exposures at Illness Onset with Disease Course in Juvenile Myositis

Arthritis and Rheumatology

Volumn 68, Issue 3, 2016, Pages 761-768

  Habers, G Esther A ^a   Huber, Adam M ^b   Mamyrova, Gulnara ^c   Targoff, Ira N ^d   O’Hanlon, Terrance P ^e   Adams, Sharon ^f   Pandey, Janardan P ^g   Boonacker, Chantal ^a   Van Brussel, Marco ^a   Miller, Frederick W ^e   Van Royen Kerkhof, Annet ^a   Rider, Lisa G ^e   Abramson, Leslie S ^h   Albert, Daniel A ^h   April Bingham, C ^h   Bohnsack, John F ^h   Bowyer, Suzanne ^h   Burnham, Jon M ^h   Carrasco, Ruy ^h   Cartwright, Victoria W ^h   Cawkwell, Gail D ^h   Cron, Randy Q ^h   Curiel, Rodolfo ^h   Eichenfield, Andrew H ^h   Finkel, Terri H ^h   Fuhlbrigge, Robert C ^h   Gabriel, Christos A ^h   George, Stephen W ^h   Gewanter, Harry L ^h   Goldbach Mansky, Raphaela ^h   Goldmuntz, Ellen A ^h   Goldsmith, Donald P ^h   Haftel, Hillary M ^h   Hawkins Holt, Melissa ^h   Henrickson, Michael ^h   Higgins, Gloria C ^h   Roger Hollister, J ^h   Imundo, Lisa ^h   Jacobs, Jerry C ^h   Jansen, Anna ^h   Jarvis, James ^h   Jones, Olcay Y ^h   Jung, Lawrence K ^h   Katona, Ildy M ^h   Kimura, Yukiko ^h   Patrick Knibbe, W ^h   Lang, Bianca A ^h   Lindsley, Carol B ^h   Mitchell, Stephen R ^h   Moallem, Jack ^h   Olson, Judyann C ^h   Oral, Elif A ^h   Pachman, Lauren M ^h   Passo, Murray H ^h   Perez, Maria D ^h   Person, Donald A ^h   Plotz, Paul H ^h   Punaro, Marilyn G ^h   Ray, Linda I ^h   Rennebohm, Robert M ^h   Rivas Chacon, Rafael F ^h   Rothman, Deborah ^h   Shaham, Bracha ^h   Sheets, Robert M ^h   Sherry, David D ^h   Soep, Jennifer ^h   Sundel, Robert P ^h   Vogelgesang, Scott A ^h   Wallace, Carol A ^h   White, Patience H ^h   Wu, Lan ^h   Zeme, Lawrence S ^h   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b DALHOUSIE UNIVERSITY   (Canada)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d UNIVERSITY OF OKLAHOMA   (United States)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FRUCTOSE BISPHOSPHATE ALDOLASE; HLA DQA1 ANTIGEN; HLA DRB1 ANTIGEN; IMMUNOGLOBULIN ALLOTYPE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR;

ARTICLE; CHILD; CLINICAL FEATURE; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; GASTROINTESTINAL INFECTION; GENETIC POLYMORPHISM; HUMAN; IMMUNOGENETICS; INFECTION; JUVENILE CONNECTIVE TISSUE MYOSITIS; JUVENILE DERMATOMYOSITIS; JUVENILE MYOSITIS; JUVENILE POLYMYOSITIS; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MYOSITIS; PHOTOSENSITIVITY; POLYMYOSITIS; PRIORITY JOURNAL; RADIATION EXPOSURE; RASH; SCORING SYSTEM; ULTRAVIOLET RADIATION; CHRONIC DISEASE; FEMALE; GENETICS; IMMUNOLOGY; MALE; PATHOPHYSIOLOGY; REGISTER; STATISTICAL MODEL;

AUTOANTIBODIES; CHILD; CHRONIC DISEASE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MYOSITIS; POLYMORPHISM, GENETIC; REGISTRIES;

EID: 84963803930     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39466     Document Type: Article

References (29)

1. Huber AM, Mamyrova G, Lachenbruch PA, Lee JA, Katz JD, Targoff IN, et al., Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken) 2014; 66: 732-40.
2. Shah M, Mamyrova G, Targoff IN, Huber AM, Malley JD, Rice MM, et al., The clinical phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 2013; 92: 25-41.
3. Huber AM, Lang B, LeBlanc CM, Birdi N, Bolaria RK, Malleson P, et al., Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 2000; 43: 541-9.
4. Ponyi A, Constantin T, Balogh Z, Szalai Z, Borgulya G, Molnar K, et al., Disease course, frequency of relapses and survival of 73 patients with juvenile or adult dermatomyositis. Clin Exp Rheumatol 2005; 23: 50-6.
5. Bingham A, Mamyrova G, Rother KI, Oral E, Cochran E, Premkumar A, et al., Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity. Medicine (Baltimore) 2008; 87: 70-86.
6. Ravelli A, Trail L, Ferrari C, Ruperto N, Pistorio A, Pilkington C, et al., Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res (Hoboken) 2010; 62: 63-72.
7. Rider LG, Lachenbruch PA, Monroe JB, Ravelli A, Cabalar I, Feldman BM, et al., Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the Myositis Damage Index. Arthritis Rheum 2009; 60: 3425-35.
8. Pachman LM, Liotta-Davis MR, Hong DK, Kinsella TR, Mendez EP, Kinder JM, et al., TNFα-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor α, disease duration, and pathologic calcifications. Arthritis Rheum 2000; 43: 2368-77.
9. Miles L, Bove KE, Lovell D, Wargula JC, Bukulmez H, Shao M, et al., Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients. Arthritis Rheum 2007; 57: 1183-91.
10. Christen-Zaech S, Seshadri R, Sundberg J, Paller AS, Pachman LM., Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis. Arthritis Rheum 2008; 58: 571-6.
11. Patwardhan A, Rennebohm R, Dvorchik I, Spencer CH., Is juvenile dermatomyositis a different disease in children up to three years of age at onset than in children above three years at onset? A retrospective review of 23 years of a single center’s experience. Pediatr Rheumatol Online J 2012; 10: 34.
12. Mamyrova G, O’Hanlon TP, Sillers L, Malley K, James-Newton L, Parks CG, et al., Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis. Arthritis Rheum 2008; 58: 3941-50.
13. Martin N, Krol P, Smith S, Beard L, Pilkington CA, Davidson J, et al., Comparison of children with onset of juvenile dermatomyositis symptoms before or after their fifth birthday in a UK and Ireland juvenile dermatomyositis cohort study. Arthritis Care Res (Hoboken) 2012; 64: 1665-72.
14. Bohan A, Peter JB., Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-7.
15. Rider LG, Shah M, Mamyrova G, Huber AM, Rice MM, Targoff IN, et al., The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 2013; 92: 223-43.
16. Targoff IN, Mamyrova G, Trieu EP, Perurena O, Koneru B, O’Hanlon TP, et al., A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum 2006; 54: 3682-9.
17. Shah M, Targoff IN, Rice MM, Miller FW, Rider LG., Ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis. Arthritis Rheum 2013; 65: 1934-41.
18. Rider LG, Wu L, Mamyrova G, Targoff IN, Miller FW., Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) 2010; 49: 2381-90.
19. Mamyrova G, O’Hanlon TP, Monroe JB, Carrick DM, Malley JD, Adams S, et al., Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians. Arthritis Rheum 2006; 54: 3979-87.
20. O’Hanlon TP, Rider LG, Schiffenbauer A, Targoff IN, Malley K, Pandey JP, et al., Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies. Arthritis Rheum 2008; 58: 3239-46.
21. Stringer E, Singh-Grewal D, Feldman BM., Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features. Arthritis Rheum 2008; 58: 3585-92.
22. Manlhiot C, Liang L, Tran D, Bitnun A, Tyrrell PN, Feldman BM., Assessment of an infectious disease history preceding juvenile dermatomyositis symptom onset. Rheumatology (Oxford) 2008; 47: 526-9.
23. Pachman LM, Lipton R, Ramsey-Goldman R, Shamiyeh E, Abbott K, Mendez EP, et al., History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. Arthritis Rheum 2005; 53: 166-72.
24. Pachman LM, Abbott K, Sinacore JM, Amoruso L, Dyer A, Lipton R, et al., Duration of illness is an important variable for untreated children with juvenile dermatomyositis. J Pediatr 2006; 148: 247-53.
25. Mathiesen P, Hegaard H, Herlin T, Zak M, Pedersen FK, Nielsen S., Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study. Scand J Rheumatol 2012; 41: 50-8.
26. Miller FW, Waite KA, Biswas T, Plotz PH., The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity. Proc Natl Acad Sci USA 1990; 87: 9933-7.
27. Sanner H, Kirkhus E, Merckoll E, Tollisen A, Roisland M, Lie BA, et al., Long-term muscular outcome and predisposing and prognostic factors in juvenile dermatomyositis: a case-control study. Arthritis Care Res (Hoboken) 2010; 62: 1103-11.
28. Sanner H, Gran JT, Sjaastad I, Flato B., Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset. Rheumatology (Oxford) 2009; 48: 1541-7.
29. Rider LG, Katz JD, Jones OY., Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheum Dis Clin North Am 2013; 39: 877-904.